Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer.
Lee VH, Tin VP, Choy TS, Lam KO, Choi CW, Chung LP, Tsang JW, Ho PP, Leung DK, Ma ES, Liu J, Shek TW, Kwong DL, Leung TW, Wong MP. Lee VH, et al. Among authors: leung tw, leung dk. J Thorac Oncol. 2013 Sep;8(9):1148-55. doi: 10.1097/JTO.0b013e31829f684a. J Thorac Oncol. 2013. PMID: 23945384 Free article.
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma.
Lee VH, Leung DK, Luk MY, Tong CC, Law MW, Ng SC, Wong KK, Poon RT, Kwong DL, Leung TW. Lee VH, et al. Among authors: leung tw, leung dk. Onco Targets Ther. 2015 Nov 20;8:3457-64. doi: 10.2147/OTT.S92473. eCollection 2015. Onco Targets Ther. 2015. PMID: 26640386 Free PMC article.
Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib.
Lee VH, Leung DK, Choy TS, Lam KO, Lam PM, Leung TW, Kwong DL. Lee VH, et al. Among authors: leung tw, leung dk. BMC Cancer. 2016 Feb 24;16:147. doi: 10.1186/s12885-016-2201-9. BMC Cancer. 2016. PMID: 26911310 Free PMC article. Clinical Trial.
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
Lee VHF, Kwong DLW, Lam KO, Lai YC, Li Y, Tong CC, Ho PPY, Chan WL, Wong LS, Leung DKC, Chan SY, Chan FT, Leung TW, Lee AWM. Lee VHF, et al. Medicine (Baltimore). 2017 Apr;96(15):e6518. doi: 10.1097/MD.0000000000006518. Medicine (Baltimore). 2017. PMID: 28403082 Free PMC article. Clinical Trial.
79 results